(NYSE: PFE) Pfizer's forecast annual revenue growth rate of 4.29% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10%.
Pfizer's revenue in 2024 is $55,094,000,000.On average, 6 Wall Street analysts forecast PFE's revenue for 2024 to be $343,552,335,577,473, with the lowest PFE revenue forecast at $336,178,330,240,191, and the highest PFE revenue forecast at $347,370,939,199,578. On average, 6 Wall Street analysts forecast PFE's revenue for 2025 to be $352,446,687,789,289, with the lowest PFE revenue forecast at $347,880,581,231,638, and the highest PFE revenue forecast at $359,788,982,872,714.
In 2026, PFE is forecast to generate $352,669,996,882,213 in revenue, with the lowest revenue forecast at $347,254,592,714,196 and the highest revenue forecast at $364,582,920,464,422.